Ivax Pharmaceuticals

Follow the Teva Pharmaceuticals company page www.linkedin.com/company/teva-pharmaceuticals for information, career opportunities and the latest company updates. In January 2006, IVAX was acquired by Teva Pharmaceutical Industries Ltd., expanding into a unique company that has become the clear global leader in generic pharmaceuticals and a major player in the global healthcare industry. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.